Turbogen Reports Narrowed Net Loss Amid Increased R&D and Operating Expenses

Turbogen Ltd., a developer of combined heat and power systems using multi-fuel microturbines, announced its financial results for the six months ending June 30, 2026. The company reported a 45% reduction in its net loss, which decreased to $4.2 million from $7.6 million in the same period of 2025. This improvement was primarily driven by a positive $6.4 million change in the fair value of option warrants and debt settlement effects, partially offset by increased operating expenses.

Despite the reduced net loss, the company's operating loss widened to $5.2 million, compared to $2.3 million in the prior year's comparable period. Research and development expenses surged to $1.9 million from $0.6 million, attributed to increased activity, material costs, subcontractor expenses, preparations for large-scale production, and stock-based payments. Management and general expenses also rose significantly to $3.1 million from $1.4 million, due to stock-based payments and professional fees related to its Nasdaq listing.

Turbogen's cash and cash equivalents stood at $7.2 million as of June 30, 2026, up from $3.9 million at the end of 2025. Net cash used in operating activities was $2.7 million, an increase from $1.4 million in the prior year's period. The company's positive shareholders' equity reached $1.6 million as of June 30, 2026, a $4.7 million improvement from December 31, 2025.

"Our strong cash balance, along with the $5 million we raised in August, supports our commercialization readiness," stated Yaron Galboa, CEO of Turbogen. "Our Nasdaq listing is a significant milestone, and we expect it to broaden our exposure to U.S. investors as we advance our commercial strategy."